Silve Vicent leads the Oncogenes and Effector Targets (OnTARGET) group at Center for Applied Medical Research (CIMA) (Pamplona, SPAIN) and is Associated Lecturer at the University of Navarra. His studies have centered around two main topics in the RAS field: 1) to develop integrative gene expression analysis to identify central KRAS effectors across tumors, and 2) to implement integrative approaches to uncover novel therapeutic strategies for the treatment of mutant KRAS tumors. His group has made significant contributions to the field published in top journals (Macaya et al, Nat Comms, 2023; Entrialgo-Cadierno et al, Mol Cancer, 2023; Erice et al, Clin Cancer Res, 2023; Vallejo et al, J Hepatol, 2021; Valencia et al, JCI, 2020; Roman et al, Cancer Res, 2019; Vallejo et al, Nat Comms, 2017).
He is member of the Spanish Cancer Network (CIBERONC), the Spanish Alliance on Pancreatic Cancer Research (ALIPANC), the European Network for the Study of Cholangiocarcinoma (ENSCCA) and Precision Biliary Tract Network, and the Health Research Institute of Navarra (IdISNa).
